Veerhealth’s Personal Care Push Gains Traction with Regulatory Clearance and New Order

Veerhealth Care Ltd has received mandatory regulatory approval from the Gujarat Food and Drug Authority (FDA), enabling it to manufacture and supply personal care products for a leading Indian marketplace company. The approval marks a significant milestone in the company’s expansion into contract manufacturing.

 

Key highlights:

 

- The Gujarat FDA clearance covers skin care and face care products under the personal care category

 

- Veerhealth has also received its first commercial order post-approval, initiating production for a top-tier e-commerce platform

 

- The company plans to expand its product portfolio under this contract, adding more SKUs in the coming months

 

- Manufacturing will take place at Veerhealth’s Vapi facility, which complies with Ayurvedic GMP and Cosmetic GMP standards

 

- This development follows Veerhealth’s recent USFDA audit clearance, positioning it for both domestic and international growth

 

Strategic context:

 

- The approval strengthens Veerhealth’s credibility in regulated markets and opens doors for future B2B partnerships

 

- It aligns with the company’s goal to scale its Ayuveer brand and white-label offerings

 

Sources: BSE India, Rediff MoneyWiz, Business Upturn, Veerhealth Care Ltd official disclosures